10-Q Filing

CIGNA GROUP CIK: 1739940 Q1 2019

Filing Information

Form Type	10-Q
Accession Number	`0001104659-19-026396`
Period End Date	20190331
Filing Date	20190502
Fiscal Year	2019
Fiscal Period	Q1
XBRL Instance	ci-20190331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 86 Income Statement 36 Cash Flow Statement 78 Stockholders Equity 36 Comprehensive Income 12

Balance Sheet 86 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.98B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.97B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.77B	USD	Point-in-time
Common stock shares issued	`CommonStockSharesIssued`	384.00M	shares	Point-in-time
Common stock shares issued	`CommonStockSharesIssued`	381.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.85B	USD	Point-in-time
Common stock shares authorized	`CommonStockSharesAuthorized`	600.00M	shares	Point-in-time
Common stock shares authorized	`CommonStockSharesAuthorized`	600.00M	shares	Point-in-time
Investments	`ShortTermInvestments`	$2.04B	USD	Point-in-time
Investments	`ShortTermInvestments`	$1.66B	USD	Point-in-time
Accounts receivable, net	`ReceivablesNetCurrent`	$10.94B	USD	Point-in-time
Accounts receivable, net	`ReceivablesNetCurrent`	$10.47B	USD	Point-in-time
Inventories	`InventoryNet`	$2.38B	USD	Point-in-time
Inventories	`InventoryNet`	$2.82B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.24B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.18B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$21.14B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$20.43B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$26.93B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$27.26B	USD	Point-in-time
Reinsurance recoverables	`ReinsuranceRecoverablesNonCurrent`	$5.51B	USD	Point-in-time
Reinsurance recoverables	`ReinsuranceRecoverablesNonCurrent`	$5.38B	USD	Point-in-time
Deferred policy acquisition costs	`DeferredPolicyAcquisitionCosts`	$2.82B	USD	Point-in-time
Deferred policy acquisition costs	`DeferredPolicyAcquisitionCosts`	$2.82B	USD	Point-in-time
Property and equipment	`PropertyPlantAndEquipmentNet`	$4.56B	USD	Point-in-time
Property and equipment	`PropertyPlantAndEquipmentNet`	$4.52B	USD	Point-in-time
Goodwill	`Goodwill`	$44.51B	USD	Point-in-time
Goodwill	`Goodwill`	$44.54B	USD	Point-in-time
Other intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$38.34B	USD	Point-in-time
Other intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$39.00B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$2.28B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.63B	USD	Point-in-time
Separate account assets	`SeparateAccountAssets`	$8.08B	USD	Point-in-time
Separate account assets	`SeparateAccountAssets`	$7.84B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$154.35B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$153.23B	USD	Point-in-time
Current insurance and contractholder liabilities	`InsuranceAndContractholderLiabilitiesCurrent`	$7.06B	USD	Point-in-time
Current insurance and contractholder liabilities	`InsuranceAndContractholderLiabilitiesCurrent`	$6.80B	USD	Point-in-time
Pharmacy and service costs payable	`PharmacyAndServiceCostsPayable`	$10.70B	USD	Point-in-time
Pharmacy and service costs payable	`PharmacyAndServiceCostsPayable`	$11.14B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.49B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.37B	USD	Point-in-time
Accrued expenses and other liabilities	`AccruedExpensesAndOtherLiabilities`	$7.07B	USD	Point-in-time
Accrued expenses and other liabilities	`AccruedExpensesAndOtherLiabilities`	$7.36B	USD	Point-in-time
Short-term debt	`DebtCurrent`	$2.92B	USD	Point-in-time
Short-term debt	`DebtCurrent`	$2.96B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$31.89B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$32.97B	USD	Point-in-time
Non-current insurance and contractholder liabilities	`InsuranceAndContractholderLiabilitiesNoncurrent`	$20.04B	USD	Point-in-time
Non-current insurance and contractholder liabilities	`InsuranceAndContractholderLiabilitiesNoncurrent`	$19.97B	USD	Point-in-time
Deferred tax liabilities, net	`DeferredTaxLiabilitiesNoncurrent`	$9.40B	USD	Point-in-time
Deferred tax liabilities, net	`DeferredTaxLiabilitiesNoncurrent`	$9.45B	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$3.47B	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$3.83B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$39.52B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$37.57B	USD	Point-in-time
Separate account liabilities	`SeparateAccountsLiability`	$7.84B	USD	Point-in-time
Separate account liabilities	`SeparateAccountsLiability`	$8.08B	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$111.90B	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$112.15B	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$38.00M	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$37.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$4.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$4.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$27.75B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$27.86B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.71B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.28B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$16.43B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$15.09B	USD	Point-in-time
Less: treasury stock, at cost	`TreasuryStockValue`	$104.00M	USD	Point-in-time
Less: treasury stock, at cost	`TreasuryStockValue`	$595.00M	USD	Point-in-time
TOTAL SHAREHOLDERS' EQUITY	`StockholdersEquity`	$42.41B	USD	Point-in-time
TOTAL SHAREHOLDERS' EQUITY	`StockholdersEquity`	$41.03B	USD	Point-in-time
Other noncontrolling interests	`MinorityInterest`	$7.00M	USD	Point-in-time
Other noncontrolling interests	`MinorityInterest`	$5.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.71B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.20B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$42.41B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$41.03B	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$154.35B	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$153.23B	USD	Point-in-time
Shareholders' Equity Per Share	`ShareholdersEquityPerShare`	$107.71	USD	Point-in-time
Shareholders' Equity Per Share	`ShareholdersEquityPerShare`	$111.52	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$9.00B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$9.97B	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$346.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$329.00M	USD	1 Quarter
Total revenues	`Revenues`	$11.41B	USD	1 Quarter
Total revenues	`Revenues`	$37.95B	USD	1 Quarter
Medical costs and other benefit expenses	`PolicyholderBenefitsAndClaimsIncurredNet`	$6.77B	USD	1 Quarter
Medical costs and other benefit expenses	`PolicyholderBenefitsAndClaimsIncurredNet`	$7.62B	USD	1 Quarter
Pharmacy and other service costs	`CostOfGoodsAndServicesSold`	$24.05B	USD	1 Quarter
Pharmacy and other service costs	`CostOfGoodsAndServicesSold`	$561.00M	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.75B	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$3.30B	USD	1 Quarter
Amortization of other acquired intangible assets	`AmortizationOfIntangibleAssets`	$27.00M	USD	1 Quarter
Amortization of other acquired intangible assets	`AmortizationOfIntangibleAssets`	$743.00M	USD	1 Quarter
Total benefits and expenses	`BenefitsLossesAndExpenses`	$35.72B	USD	1 Quarter
Total benefits and expenses	`BenefitsLossesAndExpenses`	$10.11B	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$1.31B	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$2.23B	USD	1 Quarter
Interest expense and other	`OtherNonoperatingIncomeExpense`	$-57.00M	USD	1 Quarter
Interest expense and other	`OtherNonoperatingIncomeExpense`	$-452.00M	USD	1 Quarter
Net realized investment gains (losses)	`RealizedInvestmentGainLoss`	$10.00M	USD	1 Quarter
Net realized investment gains (losses)	`RealizedInvestmentGainLoss`	$-33.00M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.79B	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.22B	USD	1 Quarter
Total income taxes	`IncomeTaxExpenseBenefit`	$416.00M	USD	1 Quarter
Total income taxes	`IncomeTaxExpenseBenefit`	$301.00M	USD	1 Quarter
Net Income	`ProfitLoss`	$1.37B	USD	1 Quarter
Net Income	`ProfitLoss`	$917.00M	USD	1 Quarter
Less: net income (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$4.00M	USD	1 Quarter
Less: net income (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.00M	USD	1 Quarter
Shareholders' net income	`NetIncomeLossAvailableToCommonStockholdersBasic`	$915.00M	USD	1 Quarter
Shareholders' net income	`NetIncomeLossAvailableToCommonStockholdersBasic`	$1.37B	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$3.61	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$3.78	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$3.72	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$3.56	USD	1 Quarter

Cash Flow Statement 78 line items

Line Item	Tag	Value	Unit	Period
Net Income	`ProfitLoss`	$1.37B	USD	1 Quarter
Net Income	`ProfitLoss`	$917.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$897.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$140.00M	USD	1 Quarter
Realized investment (gains) losses	`RealizedInvestmentGainLoss`	$10.00M	USD	1 Quarter
Realized investment (gains) losses	`RealizedInvestmentGainLoss`	$-33.00M	USD	1 Quarter
Deferred income taxes (benefits)	`IncreaseDecreaseInDeferredIncomeTaxes`	$-9.00M	USD	1 Quarter
Deferred income taxes (benefits)	`IncreaseDecreaseInDeferredIncomeTaxes`	$162.00M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsAndOtherReceivables`	$396.00M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsAndOtherReceivables`	$53.00M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-440.00M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-94.00M	USD	1 Quarter
Deferred policy acquisition costs	`IncreaseDecreaseInDeferredPolicyAcquisitionCosts`	$51.00M	USD	1 Quarter
Deferred policy acquisition costs	`IncreaseDecreaseInDeferredPolicyAcquisitionCosts`	$76.00M	USD	1 Quarter
Reinsurance recoverables and other assets	`IncreaseDecreaseInReinsuranceRecoverable`	$-124.00M	USD	1 Quarter
Reinsurance recoverables and other assets	`IncreaseDecreaseInReinsuranceRecoverable`	$-51.00M	USD	1 Quarter
Insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$849.00M	USD	1 Quarter
Insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$360.00M	USD	1 Quarter
Pharmacy and service costs payable	`IncreaseDecreaseInPharmacyAndServiceCostsPayable`	$444.00M	USD	1 Quarter
Pharmacy and service costs payable	`IncreaseDecreaseInPharmacyAndServiceCostsPayable`	$-124.00M	USD	1 Quarter
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities`	$91.00M	USD	1 Quarter
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities`	$193.00M	USD	1 Quarter
Other, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-83.00M	USD	1 Quarter
Other, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$8.00M	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$3.19B	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.02B	USD	1 Quarter
Fixed maturities and equity securities	`ProceedsFromSaleOfDebtAndEquitySecurities`	$499.00M	USD	1 Quarter
Fixed maturities and equity securities	`ProceedsFromSaleOfDebtAndEquitySecurities`	$1.47B	USD	1 Quarter
Fixed maturities and equity securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities`	$297.00M	USD	1 Quarter
Fixed maturities and equity securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities`	$319.00M	USD	1 Quarter
Commercial mortgage loans	`ProceedsFromCollectionOfLoansReceivable`	$28.00M	USD	1 Quarter
Commercial mortgage loans	`ProceedsFromCollectionOfLoansReceivable`	$89.00M	USD	1 Quarter
Other sales, maturities and repayments (primarily short-term and other long-term investments)	`ProceedsFromSaleAndMaturityOfOtherInvestments`	$367.00M	USD	1 Quarter
Other sales, maturities and repayments (primarily short-term and other long-term investments)	`ProceedsFromSaleAndMaturityOfOtherInvestments`	$112.00M	USD	1 Quarter
Fixed maturities and equity securities	`PaymentsToAcquireAvailableForSaleSecurities`	$2.26B	USD	1 Quarter
Fixed maturities and equity securities	`PaymentsToAcquireAvailableForSaleSecurities`	$1.09B	USD	1 Quarter
Commercial mortgage loans	`PaymentsToAcquireMortgageNotesReceivable`	$95.00M	USD	1 Quarter
Commercial mortgage loans	`PaymentsToAcquireMortgageNotesReceivable`	$68.00M	USD	1 Quarter
Other (primarily short-term and other long-term investments)	`PaymentsToAcquireOtherInvestments`	$206.00M	USD	1 Quarter
Other (primarily short-term and other long-term investments)	`PaymentsToAcquireOtherInvestments`	$388.00M	USD	1 Quarter
Property and equipment purchases	`PaymentsToAcquirePropertyPlantAndEquipment`	$103.00M	USD	1 Quarter
Property and equipment purchases	`PaymentsToAcquirePropertyPlantAndEquipment`	$194.00M	USD	1 Quarter
Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	1 Quarter
Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$6.00M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.70B	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$475.00M	USD	1 Quarter
Deposits and interest credited to contractholder deposit funds	`AdditionsToContractHoldersFunds`	$247.00M	USD	1 Quarter
Deposits and interest credited to contractholder deposit funds	`AdditionsToContractHoldersFunds`	$292.00M	USD	1 Quarter
Withdrawals and benefit payments from contractholder deposit funds	`WithdrawalFromContractHoldersFunds`	$306.00M	USD	1 Quarter
Withdrawals and benefit payments from contractholder deposit funds	`WithdrawalFromContractHoldersFunds`	$251.00M	USD	1 Quarter
Net change in short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$-3.00M	USD	1 Quarter
Net change in short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$-1.05B	USD	1 Quarter
Repayment of long-term debt	`RepaymentsOfLongTermDebt`	$1.00B	USD	1 Quarter
Repayment of long-term debt	`RepaymentsOfLongTermDebt`	$131.00M	USD	1 Quarter
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$462.00M	USD	1 Quarter
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$310.00M	USD	1 Quarter
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$20.00M	USD	1 Quarter
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$53.00M	USD	1 Quarter
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-73.00M	USD	1 Quarter
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-92.00M	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.53B	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-530.00M	USD	1 Quarter
Effect of foreign currency rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$4.00M	USD	1 Quarter
Effect of foreign currency rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-12.00M	USD	1 Quarter
Net increase / (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.12B	USD	1 Quarter
Net increase / (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-201.00M	USD	1 Quarter
Cash and cash equivalents, January 1,	`CashAndCashEquivalentsAtCarryingValue`	$4.98B	USD	Point-in-time
Cash and cash equivalents, January 1,	`CashAndCashEquivalentsAtCarryingValue`	$2.97B	USD	Point-in-time
Cash and cash equivalents, January 1,	`CashAndCashEquivalentsAtCarryingValue`	$2.77B	USD	Point-in-time
Cash and cash equivalents, January 1,	`CashAndCashEquivalentsAtCarryingValue`	$3.85B	USD	Point-in-time
Cash and cash equivalents, March 31,	`CashAndCashEquivalentsAtCarryingValue`	$4.98B	USD	Point-in-time
Cash and cash equivalents, March 31,	`CashAndCashEquivalentsAtCarryingValue`	$2.97B	USD	Point-in-time
Cash and cash equivalents, March 31,	`CashAndCashEquivalentsAtCarryingValue`	$2.77B	USD	Point-in-time
Cash and cash equivalents, March 31,	`CashAndCashEquivalentsAtCarryingValue`	$3.85B	USD	Point-in-time
Income taxes paid, net of refunds	`IncomeTaxesPaidNet`	$31.00M	USD	1 Quarter
Income taxes paid, net of refunds	`IncomeTaxesPaidNet`	$29.00M	USD	1 Quarter
Interest paid	`InterestPaidNet`	$46.00M	USD	1 Quarter
Interest paid	`InterestPaidNet`	$377.00M	USD	1 Quarter

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Total Equity, beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.71B	USD	Point-in-time
Total Equity, beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.20B	USD	Point-in-time
Total Equity, beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$42.41B	USD	Point-in-time
Total Equity, beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$41.03B	USD	Point-in-time
Cumulative effect of new accounting guidance	`CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption`	$-15.00M	USD	Point-in-time
Cumulative effect of new accounting guidance	`CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption`	$58.00M	USD	Point-in-time
Reclassification adjustment related to U.S. tax reform legislation	`TaxCutsAndJobsActOf2017ReclassificationFromAociTaxEffect`	-	USD	1 Quarter
Effect of issuing stock for employee benefit plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$22.00M	USD	1 Quarter
Effect of issuing stock for employee benefit plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$75.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-226.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$429.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$915.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$1.37B	USD	1 Quarter
Common dividends declared (per share: $0.04)	`DividendsCommonStockCash`	$10.00M	USD	1 Quarter
Common dividends declared (per share: $0.04)	`DividendsCommonStockCash`	$15.00M	USD	1 Quarter
Repurchase of common stock	`TreasuryStockValueAcquiredCostMethod`	$275.00M	USD	1 Quarter
Repurchase of common stock	`TreasuryStockValueAcquiredCostMethod`	$462.00M	USD	1 Quarter
Other transactions impacting noncontrolling interest	`NoncontrollingInterestOtherChanges`	$-3.00M	USD	1 Quarter
Other transactions impacting noncontrolling interest	`NoncontrollingInterestOtherChanges`	-	USD	1 Quarter
Total Equity, end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.71B	USD	Point-in-time
Total Equity, end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.20B	USD	Point-in-time
Total Equity, end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$42.41B	USD	Point-in-time
Total Equity, end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$41.03B	USD	Point-in-time
Beginning Balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$49.00M	USD	Point-in-time
Beginning Balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$37.00M	USD	Point-in-time
Beginning Balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$38.00M	USD	Point-in-time
Beginning Balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$49.00M	USD	Point-in-time
Other comprehensive income (loss)	`TemporaryEquityOtherComprehensiveIncome`	$-2.00M	USD	1 Quarter
Other comprehensive income (loss)	`TemporaryEquityOtherComprehensiveIncome`	$-2.00M	USD	1 Quarter
Net income (loss)	`TemporaryEquityNetIncome`	$3.00M	USD	1 Quarter
Net income (loss)	`TemporaryEquityNetIncome`	$2.00M	USD	1 Quarter
Other transactions impacting noncontrolling interest	`TemporaryEquityOtherChanges`	-	USD	1 Quarter
Ending Balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$49.00M	USD	Point-in-time
Ending Balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$37.00M	USD	Point-in-time
Ending Balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$38.00M	USD	Point-in-time
Ending Balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$49.00M	USD	Point-in-time

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Shareholders' net income	`NetIncomeLossAvailableToCommonStockholdersBasic`	$915.00M	USD	1 Quarter
Shareholders' net income	`NetIncomeLossAvailableToCommonStockholdersBasic`	$1.37B	USD	1 Quarter
Net unrealized appreciation (depreciation), securities and derivatives	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$442.00M	USD	1 Quarter
Net unrealized appreciation (depreciation), securities and derivatives	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-284.00M	USD	1 Quarter
Net translation (losses) gains on foreign currencies	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$45.00M	USD	1 Quarter
Net translation (losses) gains on foreign currencies	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-24.00M	USD	1 Quarter
Postretirement benefits liability adjustment	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$-11.00M	USD	1 Quarter
Postretirement benefits liability adjustment	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$-13.00M	USD	1 Quarter
Shareholders' other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-226.00M	USD	1 Quarter
Shareholders' other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$429.00M	USD	1 Quarter
Shareholders' comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$689.00M	USD	1 Quarter
Shareholders' comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$1.80B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.